Asabys Partners — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Anaconda Biomedanaconda.bioin𝕏Series B · Dec 2019 · $22M
Anaconda Biomed develops next-generation endovascular access and protection devices.
BiotechHardwareHealthtechMedical DevicesBarcelona, ES
Trent Reutiman(CEO)inHendrik Lambert(Vice-President of Clinical & Regulatory Affairs)inDr. Iñaki GalveJordi Cardonain
BoardMaria Jose Alonso
Co-investorsYsios CapitalEuropean Investment BankInnogest Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.